Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€251.30

€251.30

0.680%
1.7
0.680%
€318.67
 
20.06.25 / Tradegate WKN: 867900 / Symbol: AMGN / Name: Amgen / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Amgen Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Amgen

sharewise wants to provide you with the best news and tools for Amgen, so we directly link to the best financial data sources.

News

Amgen Stock: Sandoz Lawsuit Threatens Blockbuster Drug Revenue
Amgen Stock: Sandoz Lawsuit Threatens Blockbuster Drug Revenue

The Swiss generics specialist Sandoz has filed an antitrust lawsuit against Amgen, challenging what it describes as illegal tactics to block competition for Enbrel, Amgen's blockbuster medication

Earnings Miss? Amgen’s Dividend Still a Bright Spot
Earnings Miss? Amgen’s Dividend Still a Bright Spot

Amgen Inc. (NASDAQ: AMGN) stock is down about 1.4% in after-hours trading despite beating estimates on the top and bottom lines in its fourth quarter 2024 earnings report. Investors appear to be

Amgen Stock: Q4 Profit Dips Despite Revenue Growth
Amgen Stock: Q4 Profit Dips Despite Revenue Growth

Amgen's fourth-quarter performance in 2024 presented a mixed picture, with profits declining despite robust revenue growth. The biotech giant reported a 18% decrease in quarterly profit to $627

2 Dividend Growth Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/820119/doctor-and-patient-talking.jpg
2 Dividend Growth Stocks to Buy and Hold Forever

When broader equities are volatile, it's tempting to focus on what's going to happen in the near term. That's why some investors resort to panic selling -- they anticipate that things will get even

3 No-Brainer Healthcare Stocks to Buy in June: https://g.foolcdn.com/editorial/images/819975/health-monitoring-getty.jpg
3 No-Brainer Healthcare Stocks to Buy in June

A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe they've found no-brainer healthcare stocks to buy in June. Here's why they

Is Amgen Stock a Buy?: https://g.foolcdn.com/editorial/images/819778/doctor-xray.jpg
Is Amgen Stock a Buy?

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this while most large-cap healthcare stocks struggle; yet it trades at just 13

The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now: https://g.foolcdn.com/editorial/images/818937/passive-income-1.jpg
The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now

The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500 index fell nearly 20% from highs made in February, only to make a full recovery

Better Weight Loss Stock: Amgen or Viking Therapeutics?: https://g.foolcdn.com/editorial/images/818492/patient-self-administering-a-shot.jpg
Better Weight Loss Stock: Amgen or Viking Therapeutics?

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders in this area, Eli Lilly and Novo Nordisk. However, several other

2 Unstoppable Dividend Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/817366/patient-taking-medicine.jpg
2 Unstoppable Dividend Stocks to Buy and Hold Forever

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past few decades, and that the lion's share of market returns can be

Beat the Nasdaq With This Cash-Gushing Dividend Stock: https://g.foolcdn.com/editorial/images/815998/amgen-dividend-stock-bullish-outlook.jpg
Beat the Nasdaq With This Cash-Gushing Dividend Stock

Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (NASDAQ: AMGN) exemplifies this strategy with

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold: https://g.foolcdn.com/editorial/images/815193/hands-behind-head-young-man.jpg
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However, you don't necessarily have to sacrifice growth for safety.

Three

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/814781/doctor-holding-elderly-patients-hand.jpg
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Equities are down this year because of Donald Trump's trade policies. The 47th U.S. president decided to impose steep tariffs on imported goods from most countries, although he has since

2 Dividend Stocks to Buy Hand Over Fist in April: https://g.foolcdn.com/editorial/images/813234/a-loose-collection-of-100-dollar-bills.jpg
2 Dividend Stocks to Buy Hand Over Fist in April

One factor that keeps some investors away from healthcare stocks is the sector's dearth of generous and reliable dividend payers. This stands to reason, as nearly every stage of drug development and

Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now: https://g.foolcdn.com/editorial/images/812978/worried-investor-looking-at-a-computer.jpg
Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now

As of Monday, the Nasdaq Composite index had tumbled more than 11% since the start of the year. The outlook for the economy is worrisome, as trade wars and promised tariffs could lead to disaster

2 Surefire Dividend Stocks That Could Pay You for Life: https://g.foolcdn.com/editorial/images/812446/patient-talking-with-a-physician.jpg
2 Surefire Dividend Stocks That Could Pay You for Life

Dividend investing is an excellent strategy for (at least) two reasons. Companies that can provide consistent payouts generally have robust underlying operations. Also, reinvesting the dividend can

Which Dow Jones Stock Is Cheaper, Amgen or Merck?: https://g.foolcdn.com/editorial/images/812386/amgen-vs-merck-stock-2025.jpg
Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in

Prediction: These 2 Stocks Will Outperform the Market Through 2030
Prediction: These 2 Stocks Will Outperform the Market Through 2030

Equity markets can move every which way from one day to the next. The more we extend our horizon, the more likely it is that stocks will provide juicy returns. Investors can cash in by putting their

3 Magnificent Growth Stocks to Buy in March
3 Magnificent Growth Stocks to Buy in March

It's often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We asked three Motley Fool contributors to pick slam-dunk growth stocks investors

2 Dividend Stocks to Buy for a Lifetime of Passive Income
2 Dividend Stocks to Buy for a Lifetime of Passive Income

Dividend investors don't buy shares of companies hoping they will suspend their payouts soon. The longer a corporation maintains its dividend program, the more attractive it is to income seekers

This Could Be the Best GLP-1 Stock to Buy in 2025
This Could Be the Best GLP-1 Stock to Buy in 2025

The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion by 2031. Hype around weight loss drugs isn't new, but when people are losing more than

Amgen (AMGN) Q4 2024 Earnings Call Transcript
Amgen (AMGN) Q4 2024 Earnings Call Transcript

Image source: The Motley Fool.

Amgen (NASDAQ: AMGN)Q4 2024 Earnings CallFeb 04, 2025, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Amgen Surpasses Q4 Earnings Forecasts
Amgen Surpasses Q4 Earnings Forecasts

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS of

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that investing in the right stock at the right time -- and holding onto it for a while

Prediction: These 3 Healthcare Stocks Will Soar in 2025
Prediction: These 3 Healthcare Stocks Will Soar in 2025

No one knows for sure what the new year will hold for the market. However, some stocks' chances for success look particularly good.

We asked three Motley Fool contributors to pick healthcare stocks